Dr Thomas John Hegarty, MD in Great Bend, KS - Medicare

Dr Thomas John Hegarty, MD is a medicare enrolled "Radiology - Radiation Oncology" physician in Great Bend, Kansas. His current practice location is 204 Cleveland St, Great Bend, Kansas. You can reach out to his office (for appointments etc.) via phone at (620) 792-5511.

Dr Thomas John Hegarty is licensed to practice in Kansas (license number 04-36965) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1730246463.

Contact Information

	Dr Thomas John Hegarty, MD
	204 Cleveland St, Great Bend, KS 67530-3563
	(620) 792-5511
	(620) 792-5977

Physician's Profile

Full Name	Dr Thomas John Hegarty
Gender	Male
Speciality
Experience	Years
Location	204 Cleveland St, Great Bend, Kansas
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Dr Thomas John Hegarty attended and graduated from in

NPI Data:

NPI Number: 1730246463
Provider Enumeration Date: 01/02/2007
Last Update Date: 01/12/2021

Medicare PECOS Information:

PECOS PAC ID:
Enrollment ID:

Medical Identifiers

Medical identifiers for Dr Thomas John Hegarty such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1730246463	NPI	-	NPPES
201089590A	Medicaid	KS
200577870A	Medicaid	OK
201089590B	Medicaid	KS

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
2085R0001X	Radiology - Radiation Oncology	49536 (Minnesota)	Secondary
2085R0001X	Radiology - Radiation Oncology	T-03795 (Kansas)	Secondary
2085R0001X	Radiology - Radiation Oncology	04-36965 (Kansas)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Thomas John Hegarty is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Thomas John Hegarty, MD 2337 E Crawford St, Salina, KS 67401-3713 Ph: (785) 823-0633	Dr Thomas John Hegarty, MD 204 Cleveland St, Great Bend, KS 67530-3563 Ph: (620) 792-5511

News Archive

Examining growing attention toward health systems strengthening

In an article published in the journal Health Policy and Planning, Tamara Hafner and Jeremy Shiffman of the Department of Public Administration and Policy at American University examine the factors behind why "many organizations involved in global health have come to direct attention and resources to the issue of health systems strengthening," especially since 2005, according to the abstract. They "construct a case history and analyze the factors shaping and inhibiting global political attention for health systems strengthening," the abstract states.

Dermatan sulfate holds potential as an additional biomarker for Sanfilippo disease

Sanfilippo disease is a rare disorder caused by the failure of enzymes to break down specific kinds of complex carbohydrates, resulting in their accumulation in cells and often severe physical and neurological problems - and sometimes early death.

Probiotics shows promise in reducing both incidence and severity of necrotizing enterocolitis

"Good" bacteria that live in our intestines have been linked with a variety of health benefits, from fighting disease to preventing obesity. In a new study, Kriston Ganguli of Massachusetts General Hospital for Children and Harvard Medical School and her colleagues have discovered another advantage to these friendly microscopic tenants: Chemicals secreted by good bacteria that typically live in the intestines of babies could reduce the frequency and severity of a common and often-lethal disease of premature infants.

Human antibody response to SARS-CoV-2

A new study published on the preprint server medRxiv* in August 2020 reports on the human antibody response in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, which is key to developing vaccines and managing the pandemic, as well as designing and executing serologic testing and interpreting their results.

Dr Thomas John Hegarty, MD - Medicare in Great Bend, KS